Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma.
Reitmajer M, Livingstone E, Thoms KM, Heppt MV, Meiss F, Gesierich A, Drexler K, Heinzerling L, Meier F, Menzer C, Schlaak M, Zimmer L, Forschner A.
Reitmajer M, et al. Among authors: zimmer l.
J Dtsch Dermatol Ges. 2025 Jan 2. doi: 10.1111/ddg.15604. Online ahead of print.
J Dtsch Dermatol Ges. 2025.
PMID: 39748658